1.Li J, Cao F, Yin HL, Huang ZJ, Lin ZT, Mao N, Sun B, Wang G. Ferroptosis: past, present and future. Cell Death Dis. 2020 ;11(2):88.
2.Zhi-Zhou Shi, Ze-Wen Fan , Yun-Xia Chen , Xiu-Feng Xie , Wen Jiang , Wen-Jun Wang, Yun-Tan Qiu , Jie Bai . Ferroptosis in Carcinoma: Regulatory Mechanisms and New Method for Cancer Therapy. Onco Targets Ther.. 2019 ;12:11291-11304.
3.Kang R, Kroemer G, Tang D. The Tumor Suppressor Protein p53 and the Ferroptosis Network. Free Radic Biol Med. 2019 ;133:162-168.
4. Bo Chu, Ning Kon, Delin Chen, Tongyuan Li, Tong Liu, Le Jiang, Shujuan Song, Omid Tavana, and Wei Gu.ALOX12 is required for p53-mediated tumor suppression through a distinct ferroptosis pathway. Nat Cell Biol. 2019 ;21(5):579-591.
5. Miao-Qian Shi , Fei-Fei Su , Xuan Xu, Xiong-Tao Liu , Hong-Tao Wang , Wei Zhang , Xue Li , Cheng Lian , Qiang-Sun Zheng , Zhi-Chun Feng. Cilostazol suppresses angiotensin II‑induced apoptosis in endothelial cells. Mol Med Rep. 2016;13(3):2597-2605.
6. R Hernanz, S Martínez-Revelles, R Palacios, A Martín,V Cachofeiro, A Aguado, L García-Redondo, M T Barrús,P R de Batista, A M Briones, M Salaices, M J Alonso.Toll-like receptor 4 contributes to vascular remodelling and endothelial dysfunction in angiotensin II-induced hypertension. British Journal of Pharmacolog. 2015 ;172(12):3159–3176.
7.Max J Männel, Carolin Fischer , Julian Thiele. A Non-Cytotoxic Resin for Micro-Stereolithography for Cell Cultures of HUVECs. Micromachines (Basel). 2020;11(3):246.
8. Chuanzhao Ji,Yang Yu,Min Zhang,Wenyan Yu, Shuo Dong. Loxoprofen Sodium Alleviates Oxidative Stress and Apoptosis Induced by Angiotensin II in Human Umbilical Vein Endothelial Cells (HUVECs). Drug Des Devel Ther. 2020;14:5087-5096.
9. Jisu Jeong, Jiye Lee, Juyeon Lim, Soyoung Cho, Soyoung An, Myungeun Lee, Nara Yoon, Miran Seo, Soyeon Lim, Sungha Park. Soluble RAGE attenuates AngII-induced endothelial hyperpermeability by disrupting HMGB1-mediated crosstalk between AT1R and RAGE. Exp Mol Med. 2019;51(9):1-15.
10.Weifen Zhang, Chengcheng Gai, Dejun Ding, Fang Wang,Wentong Li.Targeted p53 on Small-Molecules-Induced Ferroptosis in Cancers. Front Oncol. 2018 ;8:507.
11.Gnanapradeepan K, Basu S, Barnoud T, Budina-Kolomets A, Kung CP, Murphy ME.The p53 Tumor Suppressor in the Control of Metabolism and Ferroptosis.Front Endocrinol (Lausanne). 2018 11;9:124.
12.Zhonghua Zheng, Yin Li, Gehui Jin, Tianyi Huang, Mengsha Zou, Shiwei Duan. The biological role of arachidonic acid 12-lipoxygenase (ALOX12) in various human diseases. Biomed Pharmacother. 2020 ;129:110354.
13. Dong C, Liu S, Cui Y, Guo Q.12-Lipoxygenase as a key pharmacological target in the pathogenesis of diabetic nephropathy. Eur J Pharmacol. 2020 ;879:173122
14. Bo Chu, Ning Kon, Delin Chen, Tongyuan Li, Tong Liu, Le Jiang, Shujuan Song, Omid Tavana, Wei Gu .ALOX12 is required for p53-mediated tumour suppression through a distinct ferroptosis pathway. Nat. Cell Biol. 2019 ; 21(5): 579–591.
15. L Siangjong , D H Goldman, T Kriska , K M Gauthier , E M Smyth , N Puli , G Kumar , J R Falck, W B Campbell L. Vascular hepoxilin and trioxilins mediate vasorelaxation through TP receptor inhibition in mouse arteries. Acta Physiol. Acta Physiol (Oxf). 2017;219(1):188-201.
16. Hye Young Kim , Dae Won Jeong, Ho Sun Park, Tae Yoon Lee, Hee Sun Kim. Comparison of 12-lipoxygenase expression in vascular smooth muscle cells from old normotensive Wistar-Kyoto rats with spontaneously hypertensive rats. Hypertens. Res. 2013;36(1): 65–73.
17. L. Thapa, C.M. He, H.P. Chen. Study on the expression of angiotensin II (ANG II) receptor subtype1(AT1R)in the placenta of pregnancy-induced hypertension. Placenta 2004;25(7):637–641.
18.Rona Limor , Marielle Kaplan, Orly Sharon, Esther Knoll, Michal Naidich, Gary Weisinger, Shlomo Keidar, Naftali Stern. Aldosterone up-regulates 12- and 15-li-poxygenase expression and LDL oxidation in human vascular smooth muscle cells,J. Cell. Biochem. J Cell Biochem. 2009;108(5): 1203–1210.
19. Maryam Farzaneh Behelgardi1, Saber Zahri1, Farhad Mashayekhi, Kamran Mansouri,S. Mohsen Asghari.A peptide mimicking the binding sites of VEGF-A and VEGF-B inhibits VEGFR-1/-2 driven angiogenesis, tumor growth and metastasis. Sci Rep. 2018 ;8(1):17924.
20. Ingiridur Skirnisdottir , Tomas Seidal, Helena Åkerud. The relationship of the angiogenesis regulators VEGF-A, VEGF-R1 and VEGF-R2 to p53 status and prognostic factors in epithelial ovarian carcinoma in FIGO-stages I-II. Int J Oncol. 2016 ;48(3):998-1006.
21. Yongchuan Zhang ,Yinglin Zhang, Jin Wang, Haitao Gu. Amarogentin Inhibits Liver Cancer Cell Angiogenesis after Insufficient Radiofrequency Ablation via Affecting Stemness and the p53-Dependent VEGFA/Dll4/Notch1 Pathway. Biomed Res Int . 2020;2020:5391058
22. Miles J Pfaff , Subhradip Mukhopadhyay , Mark Hoofnagle , Christine Chabasse, Rajabrata Sarkar . Sarkar. Tumor suppressor protein p53 negatively regulates ischemia-induced angiogenesis and arteriogenesis. Journal of Vascular Surgery. 2018;68(6S):222S-233S.
23. Wamidh H Talib , Lina T Al Kury. Parthenolide inhibits tumor-promoting effects of nicotine in lung cancer by inducing P53-dependent apoptosis and inhibiting VEGF expression. Biomed. Pharmacother. 2018;107:1488-1495.
24.Laura Morshaeuser , Matthias May , Maximilian Burger, Wolfgang Otto , Georg C Hutterer , Martin Pichler , Tobias Klatte , Peter Wild , Lorenz Buser, Sabine Brookman-May . p53-expression in patients with renal cell carcinoma correlates with a higher probability of disease progression and increased cancer-specific mortality after surgery but does not enhance the predictive accuracy of robust outcome models. Urol Oncol . 2018;36(3):94.e15-94.e21.
25. Xiaoxiang Chen, Kaixuan Zeng, Mu Xu1, Xiangxiang Liu, Xiuxiu Hu , Tao Xu, Bangshun He , Yuqin Pan , Huiling Sun, Shukui Wang. P53-induced miR-1249 inhibits tumor growth, metastasis, and angiogenesis by targeting VEGFA and HMGA2. Cell Death Dis. 2019 ;10(2):131.
26. William S. Powella,Joshua Rokach. Biosynthesis, biological effects, and receptors of hydroxyeicosatetraenoic acids (HETEs) and oxoeicosatetraenoic acids (oxo-ETEs) derived from arachidonic acid. Biochim Biophys Acta. 2015; 1851(4): 340–355.